Articles

IU surgeon gets $2 million for heart pump

IU School of Medicine associate professor Mark Rodefeld will use funding to further develop the pump, intended to combat a congenital heart defect that kills many children in their first year of life.

Read More

Lilly discovers social media

Eli Lilly and Co. launched its own blog this month, dubbed LillyPad, to try to start discussions about public policy and corporate social responsibility. The Indianapolis-based drugmaker also launched an accompanying Twitter feed.

Read More

Building binge hasn’t crimped hospital profits

Indianapolis-area hospitals spent billions on construction in the past decade and increasingly tried to poach patients from one another’s territories. Yet last year—one of the worst economically in recent history—21 of 26 hospitals still were able to show operating profits.

Read More

State insurance chief Cutter dies

Indiana Insurance Commissioner Carol Cutter passed away Sept. 6 in Indianapolis after a months-long struggle with illness. She was 67. Cutter had been on leave from the department since January.

Read More

Community moves to integrate doctors

Health Care watch videoCommunity Health now has about 550 physicians, either on its payroll or committed through integration contracts, who have some of their pay hinge on measures of quality and communication. CEO Bryan Mills says the hospital system is looking to add even more.

Read More

Bill could make health workers pay for FBI checks

The bill has the potential to affect more than 250,000 Indiana workers in up to 24 categories of licensed professionals, including doctors, dentists, pharmacists, nurses, chiropractors, hypnotists, dietitians and even veterinarians.

Read More

Lilly wins reversal of class action in Zyprexa suit

A U.S. appeals court in New York threw out a September 2008 ruling that said plaintiffs could pursue as a group claims that Zyprexa marketing caused them to pay more for the drug than what it was worth. The plaintiffs were seeking $6.8 billion in damages.

Read More

Lilly investing up to $150M in VC funds

The three venture funds, which will focus on drug development, may be worth a total of $750 million, up to $250 million each, and Lilly will contribute as much as 20 percent of the money.

Read More

Clarian moves to scoop up Morgan

It looks like Clarian may be back to deal-making. The Indianapolis-based hospital system has signed a letter of intent to absorb Morgan Hospital and Medical Center.

Read More

Indiana to get share of Botox settlement

Botox maker Allergan Inc. said it would pay $600 million to settle a years-long federal investigation into its marketing of the drug. Indiana will get $636,000 of that money.

Read More

Indianapolis software firm RealMed acquired

Health care software firm RealMed Corp. will keep its base of operations in Indianapolis after being acquired by health information exchange provider Availity LLC of Jacksonville, Fla. Terms of the deal announced Wednesday were not disclosed.

Read More

After health reform, Lilly looking for more

The health reform debate may have ended in Congress, but Eli Lilly and Co. remains active, sponsoring a talk about the positives of the
bill—and calling for further government efforts to help pharmaceutical research and development.

Read More